Neufeld Bella H, Reynolds Melissa M
Department of Chemistry, Colorado State University, Fort Collins, Colorado 80523.
Department of Chemistry, Colorado State University, Fort Collins, Colorado 80523; School of Biomedical Engineering, Colorado State University, Fort Collins, Colorado 80523; and Department of Chemical and Biological Engineering, Colorado State University, Fort Collins, Colorado 80523.
Biointerphases. 2016 Sep 7;11(3):031012. doi: 10.1116/1.4962266.
Bacterial colonies that reside on a surface, known as biofilms, are intrinsically impenetrable to traditional antibiotics, ultimately driving research toward an alternative therapeutic approach. Nitric oxide (NO) has gained attention for its biologically beneficial properties, particularly centered around its antibacterial capabilities. NO donors that can release the molecule under physiological conditions (such as S-nitrosothiols) can be utilized in clinical settings to combat bacterial biofilm infections. Herein the authors describe determining a critical concentration of NO necessary to cause >90% reduction of a Pseudomonas aeruginosa biofilm grown on medical grade polyurethane films. The biofilm was grown under optimal culture conditions [in nutrient broth media (NBM) at 37 °C] for 24 h before the addition of the NO donor S-nitrosoglutathione (GSNO) in NBM for an additional 24 h. The cellular viability of the biofilm after the challenge period was tested using varying concentrations of NO to determine the critical amount necessary to cause at least a 90% reduction in bacterial biofilm viability. The critical GSNO concentration was found to be 10 mM, which corresponds to 2.73 mM NO. Time kill experiments were performed on the 24 h biofilm using the critical amount of NO at 4, 8, 12, and 16 h and it was determined that the 90% biofilm viability reduction occurred at 12 h and was sustained for the entire 24 h challenge period. This critical concentration was subsequently tested for total NO release via a nitric oxide analyzer. The total amount of NO released over the 12 h challenge period was found to be 5.97 ± 0.66 × 10(-6) mol NO, which corresponds to 1.49 ± 0.17 μmol NO/ml NBM. This is the first identification of the critical NO concentration needed to elicit this biological response on a medically relevant polymer.
附着在表面的细菌菌落,即生物膜,对传统抗生素具有内在的抗穿透性,这最终推动了对替代治疗方法的研究。一氧化氮(NO)因其有益的生物学特性,特别是其抗菌能力而受到关注。能够在生理条件下释放该分子的NO供体(如S-亚硝基硫醇)可用于临床环境中对抗细菌生物膜感染。在此,作者描述了确定导致在医用级聚氨酯膜上生长的铜绿假单胞菌生物膜减少>90%所需的NO临界浓度。生物膜在最佳培养条件下(在37°C的营养肉汤培养基(NBM)中)生长24小时,然后在NBM中添加NO供体S-亚硝基谷胱甘肽(GSNO)再培养24小时。在挑战期后,使用不同浓度的NO测试生物膜的细胞活力,以确定导致细菌生物膜活力至少降低90%所需的临界量。发现临界GSNO浓度为10 mM,相当于2.73 mM NO。使用临界量的NO在4、8、12和16小时对24小时的生物膜进行时间杀灭实验,确定在12小时时生物膜活力降低90%,并在整个24小时的挑战期内持续。随后通过一氧化氮分析仪测试该临界浓度下的总NO释放量。发现在12小时的挑战期内释放的NO总量为5.97±0.66×10(-6)mol NO,相当于1.49±0.17 μmol NO/ml NBM。这是首次确定在医学相关聚合物上引发这种生物学反应所需的临界NO浓度。